INVEST-HD
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Phase 3 study testing votoplam to assess its safety and tolerability in people with Huntington's disease.
RecruitingPhase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Aberdeen, Albany, Basel +55 more (Argentina, Australia, Belgium +28 more)
Sponsor: Novartis Pharmaceuticals
Preparing a short plain-English summary.